AI-driven digital health company supporting providers in all steps of the primary care journey51-200 Employees
- Growth StageExpanding market presence
Infermedica careers
Infermedica, a leading digital health company, tackles the problem of inappropriate use of medical services and misdiagnosis, providing insurance and telemedicine companies, hospitals, and health systems with a set of AI-powered preliminary medical assessment and triage solutions.
“The broader goal is to improve customers’ performance, increase healthcare accessibility, and reduce costs. To date, our tools have been used by over 6 million users worldwide, and we are working with more than 50 companies, including Allianz Worldwide Partners, Microsoft, Global Excel, Médis, PZU Zdrowie, Sana Kliniken or Everyday Health,” says Piotr Orzechowski, Infermedica’s CEO.
We aim to make healthcare accessible, affordable, and convenient by automating primary care from symptom to outcome. 220+ people working in multi-disciplinary teams are building a B2B Medical Guidance Platform that consists of a series of connected user-facing modules built on a common intelligent core. Our solutions are being used in more than 30 countries in 24 languages, with the largest footprint in the US, DACH, and the Middle East. At the beginning of 2022, we raised $30 million in Series B funding led by the world-class growth equity investment firm One Peak.
“The broader goal is to improve customers’ performance, increase healthcare accessibility, and reduce costs. To date, our tools have been used by over 6 million users worldwide, and we are working with more than 50 companies, including Allianz Worldwide Partners, Microsoft, Global Excel, Médis, PZU Zdrowie, Sana Kliniken or Everyday Health,” says Piotr Orzechowski, Infermedica’s CEO.
We aim to make healthcare accessible, affordable, and convenient by automating primary care from symptom to outcome. 220+ people working in multi-disciplinary teams are building a B2B Medical Guidance Platform that consists of a series of connected user-facing modules built on a common intelligent core. Our solutions are being used in more than 30 countries in 24 languages, with the largest footprint in the US, DACH, and the Middle East. At the beginning of 2022, we raised $30 million in Series B funding led by the world-class growth equity investment firm One Peak.
Infermedica hasn't added any jobs yet
Get notified when Infermedica posts new jobs.
Roberto Sicconi
R&D Mgr. @IBM Italy, Watson Program Dir. @IBM Watson Research, CSO/Co-Founder @Infermedica, CTO/Co-Founder @TeleLingo. Doctorate EE @ Politecnico of Milan.
Irving Loh MD FACC FAHA FCCP FACP
Co-Founder Infermedica • @National Institutes of Health, @Cedars Sinai Medical Center
Piotr Orzechowski
Founder and CEO at Infermedica
Total raised
$44M
Funded over
8 rounds
Latest round
Series B (Jan 2022)
MoodMe • Silicon Valley • 1 week ago
Audicus • New York City • $50k – $60k • No equity • 1 week ago
Thanx • Remote • 2 weeks ago
tray.io • Remote • 2 weeks ago
Greenhouse • London • 3 weeks ago